1. Home
  2. DAL vs RMD Comparison

DAL vs RMD Comparison

Compare DAL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delta Air Lines Inc.

DAL

Delta Air Lines Inc.

HOLD

Current Price

$67.30

Market Cap

38.2B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$256.54

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAL
RMD
Founded
1924
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
DAL
RMD
Price
$67.30
$256.54
Analyst Decision
Strong Buy
Buy
Analyst Count
14
13
Target Price
$74.00
$292.27
AVG Volume (30 Days)
7.5M
979.4K
Earning Date
01-09-2026
10-30-2025
Dividend Yield
1.12%
0.94%
EPS Growth
N/A
29.59
EPS
7.09
9.77
Revenue
$62,920,000,000.00
$5,257,400,000.00
Revenue This Year
N/A
$9.81
Revenue Next Year
$5.80
$7.31
P/E Ratio
$9.46
$26.26
Revenue Growth
4.33
9.36
52 Week Low
$34.74
$199.92
52 Week High
$69.98
$293.81

Technical Indicators

Market Signals
Indicator
DAL
RMD
Relative Strength Index (RSI) 67.75 54.75
Support Level $63.00 $237.63
Resistance Level $68.06 $254.10
Average True Range (ATR) 2.12 5.28
MACD 0.91 1.28
Stochastic Oscillator 93.20 92.08

Price Performance

Historical Comparison
DAL
RMD

About DAL Delta Air Lines Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: